The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Efficacy and safety of antiarrhythmics for prevention of recurrence of paroxysmal atrial fibrillation
Author(s): 
Pages: 151-154
Year: Issue:  3
Journal: ADVERSE DRUG REACTIONS JOURNAL

Keyword:  房颤复发抗心律失常药物疗效及安全性;
Abstract: 目的:评价不同抗心律失常药物在预防阵发性房颤复发中的疗效及安全性.方法:随机入选阵发性房颤转复患者,随机分为胺碘酮、普罗帕酮、阿替洛尔和对照组,接受不同药物治疗,并定期随访,终点为一年.结果:小剂量胺碘酮与普罗帕酮均可以降低房颤复发率,延长窦性节律时间,缩短再发房颤持续时间,胺碘酮的作用优于普罗帕酮.两者的毒副作用差别不大,发生率低.结论:小剂量胺碘酮和普罗帕酮均可作为预防阵发性房颤的首选药物,近期疗程的毒副作用发生率低、安全性高.
Related Articles
No related articles found